平特五不中

subscribe

The onset of Alzheimer鈥檚 disease: the importance of family history

You鈥檙e about to turn 60, and you鈥檙e fretting. Your mother has had Alzheimer鈥檚 disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer鈥檚, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.

Published: 26 Feb 2018

The Neuro joins neuroscience data sharing partnership

Canadian Open Neuroscience Platform will make disseminating and publishing data easier

Modern neuroscience research can produce massive amounts of data, which researchers can use to find patterns revealing anything from the first physiological signs of Alzheimer鈥檚 disease to a new drug target that could stop neurodegeneration. However, this data must be stored, processed, and distributed effectively.

Email address:
Published: 19 Feb 2018

A non-invasive method to detect Alzheimer鈥檚 disease

Volume in brain region linked to physiological changes characteristic of AD

New research has drawn a link between changes in the brain鈥檚 anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer鈥檚 disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.

Email address:
Published: 19 Dec 2017

New Open Science partnership will pave way for better treatments, faster

NeuroSGC created to increase volume and quality of cell assays for drug discovery

A new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases.

Email address:
Published: 6 Dec 2017

The MNI forms promising Open Science partnership with Takeda

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

Email address:
Published: 4 Dec 2017

Alan Evans receives Canada 150 medal

Senate of Canada recognizes outstanding contributions to the community听

The Senate of Canada has awarded Alan Evans a Canada 150 medal for his commitment to advancements in Alzheimer鈥檚 disease and palliative care research. He was nominated by Senator Judith Seidman, a former research fellow at the Montreal Neurological Institute and Hospital, and Associate Professor of the 平特五不中 School of Social Work.

Email address:
Published: 27 Nov 2017

Three MNI researchers receive ALS funding

Grants for Heather Durham, Stefano Stifani and Jay Ross total just over $2 million听

Three MNI researchers have received grants from the ALS Society of Canada worth a total of more than $2 million. 听

Email address:
Published: 24 Nov 2017

Now you like it, now you don鈥檛

Brain stimulation can change how much we enjoy and value music

Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, be it classical or heavy metal, arises, among other aspects, from structural features of music, such as chord or rhythm patterns that generate anticipation and expectancy.

Email address:
Published: 20 Nov 2017

Transformative donation of $16 million establishes new autism research centre at the Montreal Neurological Institute

The Azrieli Centre for Autism Research will foster innovations in therapy and a better understanding of Autism Spectrum Disorder.

A new research centre in Montreal will help lift the shroud of mystery surrounding autism spectrum disorder (ASD), and lead to the development of better diagnostic tools and more effective therapies for people with autism.

Email address:
Published: 23 Oct 2017

The Neuro鈥檚 top brain cancer fundraiser returns

A Brilliant Night has donated a total of $1.6 million since 2015

A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.

Email address:
Published: 10 Oct 2017

Predicting when a sound will occur relies on the brain鈥檚 motor system

Research shows how the brain鈥檚 motor signals sharpen our ability to decipher complex sound flows

Whether it is dancing or just tapping one foot to the beat, we all experience how auditory signals like music can induce movement. Now new research suggests that motor signals in the brain actually sharpen sound perception, and this effect is increased when we move in rhythm with the sound.

Email address:
Published: 5 Oct 2017

Mitochondria drive cell survival in times of need

Discovery points to possible target for cancer drugs

平特五不中 researchers have discovered a mechanism through which mitochondria, the energy factory of our body鈥檚 cells, play a role in preventing cells from dying when the cells are deprived of nutrients 鈥 a finding that points to a potential target for next-generation cancer drugs.

Email address:
Published: 22 Sep 2017

Busy week for ALS research and awareness

Research symposium, public education event and ALS walk planned

Multiple events planned for this week will help educate the public about amyotrophic lateral sclerosis (ALS), a devastating disease that still has no cure.

Email address:
Published: 13 Sep 2017

Edith Hamel and Robert Zatorre elected to Royal Society of Canada

Society recognizes scholarly, research and artistic excellence.

Dr. Edith Hamel and Dr. Robert Zatorre have been elected Fellows of the Royal Society of Canada. Election to the academies of the Royal Society of Canada is the highest honour a scholar can achieve in the Arts, Humanities and Sciences.

Published: 7 Sep 2017

Onward to Open Science

The Neuro to launch open research publishing platform with F1000

A new partnership between The Neuro and F1000 will create a publishing platform for researchers that will speed the progress of neuroscience discovery.

Email address:
Published: 30 Aug 2017

Pages

The Neuro logo平特五不中 logo

The Neuro (Montreal Neurological Institute-Hospital)听is a bilingual academic healthcare institution. We are a听平特五不中 research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the 平特五不中 Health Centre.听We are听proud to be a Killam Institution, supported by the Killam Trusts.

Back to top